Page last updated: 2024-10-27

fluconazole and Chromosome-Defective Micronuclei

fluconazole has been researched along with Chromosome-Defective Micronuclei in 1 studies

Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.

Research Excerpts

ExcerptRelevanceReference
"Fluconazole was used at concentrations of 12."1.35Genotoxicity testing of fluconazole in vivo and in vitro. ( Aksoy, H; Celik, M; Unal, F; Yilmaz, S; Yüzbaşioğlu, D, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yüzbaşioğlu, D1
Unal, F1
Yilmaz, S1
Aksoy, H1
Celik, M1

Other Studies

1 other study available for fluconazole and Chromosome-Defective Micronuclei

ArticleYear
Genotoxicity testing of fluconazole in vivo and in vitro.
    Mutation research, 2008, Jan-08, Volume: 649, Issue:1-2

    Topics: Animals; Antifungal Agents; Bone Marrow Cells; Chromosome Aberrations; Fluconazole; Humans; Lymphocy

2008